期刊文献+

低分子肝素舌下含片的质量控制

Quality Control of Buccal Tablets under Lingua of LMWH
原文传递
导出
摘要 目的研究低分子肝素舌下含片的质量控制方法。方法本文采用发色底物法作为含量测定方法,检测制备的低分子肝素舌下含片的抗FXa活性;对3批低分子肝素舌下含片进行稳定性考察。结果低分子肝素舌下含片溶解后,浓度在0.25~1.0 IU·ml-1浓度范围内线性关系良好(r=0.9991);其稳定性好,性状、溶解度、含量测定均符合《中国药典》规定。结论本文制定的低分子肝素舌下含片的控制标准,能全面反映该制剂的质量,可行性好。 Objective To prepare buccal tablets under lingua of low molecular weight heparin (LMWH) and to establisha quality control method. Methods Chromomeric substrate methods were used to determine the anti-FXa activity of LMWH. A stability study was carried out on three batches of such tablets. Results The calibration curve was linear within the range of 0.25 - 1.0 IU ·ml-1 ( r = 0. 9991 ). The quality met the standard specified by Chinese Pharmacopoeia. Conclusion This preparation technology for buccal tablets under lingua of LMWH is simple and corn ensure good quality and stability.
出处 《解放军药学学报》 CAS CSCD 2015年第4期335-337,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 低分子肝素 舌下含片 质量标准 low molecular weight heparin buccal tablets under lingua quality control
  • 相关文献

参考文献5

二级参考文献76

  • 1崔慧斐,张天民.低抗凝肝素来源低分子肝素口服制剂的研究[J].中国生化药物杂志,1993,14(4):10-15. 被引量:14
  • 2汪龙,邓瑾,金玉燕,张钧寿.低分子肝素微乳及其纳米脂质体作大鼠口服抗凝效果的比较[J].江苏药学与临床研究,2005,13(2):4-6. 被引量:9
  • 3陈公英,李敏伟,陈智,顾新宇,周慧明.低分子肝素抗肝癌细胞增殖及机制研究[J].中国肿瘤,2006,15(5):343-345. 被引量:11
  • 4Prasad Y V, Minamimoto T, Yoshikawa Y, et al. In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer[ J]. Int J Pharm, 2004,271 (1-2) : 225-232.
  • 5Ito Y, Kusawake T, Prasad Y V, et al. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies[J]. Int J Pharm,2006,317(2) : 114-119.
  • 6Khashayar S, Mark D G, Andrea L B, et al. Oral low molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat [J] .J Vasc Surg,1999,30(3):526-532.
  • 7British Pharmacopoeia [ S]. Volume Ⅰ. 1998 : 667-670.
  • 8Lee Y K, Kim S K, Lee D Y, ct al. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys [ J ]. J Controlled Release, 2006,111 (3) : 290-298.
  • 9Kim S K, Lee E H, Vaishali B, et al. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates [ J ]. J Controlled Release, 2005,105 ( 1-2 ) : 32-42.
  • 10Hoffart V, Lamprecht A, Maincent P. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system[ J ]. J Controlled Release, 2006,113 ( 1 ) : 38-42.

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部